The Phosphodiesterase Inhibitor Ensifentrine Reduces Production of Proinflammatory Mediators in Well Differentiated Bronchial Epithelial Cells by Inhibiting PDE4-Reference-Cited by-同舟云学术

The Phosphodiesterase Inhibitor Ensifentrine Reduces Production of Proinflammatory Mediators in Well Differentiated Bronchial Epithelial Cells by Inhibiting PDE4

Published:2020-10-04 Issue:3 Volume:375 Page:414-429
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Turner Mark J.,Dauletbaev Nurlan,Lands Larry C.,Hanrahan John W.^ORCID

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference87 articles.

1. Dual PDE3/4 and PDE4 Inhibitors: Novel Treatments For COPD and Other Inflammatory Airway Diseases

2. Activation of wild-type and ΔF508-CFTR by phosphodiesterase inhibitors through cAMP-dependent and -independent mechanisms

3. Alcohol functionally upregulates Toll-like receptor 2 in airway epithelial cells;Bailey;Alcohol Clin Exp Res,2009

4. Flagellin concentrations in expectorations from cystic fibrosis patients;Balloy;BMC Pulm Med,2014

5. Theophylline and selective phosphodiesterase inhibitors as anti-inflammatory drugs in the treatment of bronchial asthma;Banner;Eur Respir J,1995

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ensifentrine (Ohtuvayre™) for chronic obstructive pulmonary disease;Trends in Pharmacological Sciences;2024-09

2. Inhaled Dual PDE3/4 Inhibitor Ensifentrine for Chronic Obstructive Pulmonary Disease: A Potential Therapeutic Perspective;American Journal of Respiratory and Critical Care Medicine;2024-01-15

3. Perspectives on Ensifentrine and Its Therapeutic Potential in the Treatment of COPD: Evidence to Date;International Journal of Chronic Obstructive Pulmonary Disease;2024-01

4. Polymorphism, phase transition, and physicochemical property investigation of Ensifentrine;CrystEngComm;2024

5. Therapeutic Targets and Precision Medicine in COPD: Inflammation, Ion Channels, Both, or Neither?;International Journal of Molecular Sciences;2023-12-11